Original paper
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era
Abstract
Importance
There is a need for a more refined, molecularly based classification model for glioblastoma (GBM) in the temozolomide era.Objective
To refine the existing clinically based recursive partitioning analysis (RPA) model by incorporating molecular variables.Design, Setting, and Participants
NRG Oncology RTOG 0525 specimens (n = 452) were analyzed for protein biomarkers representing key pathways in GBM by a...Paper Details
Title
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era
Published Date
Jan 18, 2017
Journal
Volume
3
Issue
6
Pages
784 - 784